The painkiller and antibiotic prices in India are set to rise slightly from April 1, following an annual revision linked to inflation.
With Semaglutide India versions hitting the market as the global weight loss and diabetes drug moves off patent, leading cardiology, endocrinology, and diabetology experts from Pune and Mumbai have issued a firm warning...
Zydus Lifesciences Limited has announced the launch of its Semaglutide injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following the expiry of the product’s patent.
The Delhi Health Budget 2026 allocates Rs 13,035 crore with focus on critical care, child healthcare, hospital expansion, and preventive services to improve access and early diagnosis.
India and Japan have signed a major agreement to invest JPY 275 billion in Maharashtra healthcare system, marking a significant step toward improving public health infrastructure in the state.
World Health Organization is marking World TB Day 2026 by calling on countries to scale up TB diagnosis tools, including faster, low-cost tests that can be used close to patients.
Lupin has secured US FDA approval for Pitolisant tablets ANDA, marking another step in its push into the central nervous system segment.
Somerset Indus Capital Partners oversubscribes Fund III at $288M, targeting healthcare expansion in India’s Tier II & III cities with scalable, impact-driven investments in diagnostics, MedTech, and healthcare delivery.
AHH-owned Nova IVF Fertility is expanding its footprint in Kerala through a strategic acquisition of a 30-year-old, most trusted fertility provider - Craft Fertility.
DrStore Healthcare Services, a connected healthcare and medical device ecosystem company, through its smart medical devices and tech platform Tracky, has launched an integrated, real-time monitoring platform designed to track patient...